Establishment of a potent weighted risk model for determining the progression of diabetic kidney disease

被引:5
作者
Zhang, Tianxiao [1 ]
Wang, Xiaodan [2 ]
Zhang, Yueying [2 ]
Yang, Ying [1 ]
Yang, Congying [1 ]
Wei, Huiyi [3 ]
Zhao, Qingbin [2 ,4 ]
机构
[1] Xi An Jiao Tong Univ, Sch Publ Hlth, Hlth Sci Ctr, Dept Epidemiol & Biostat, Xian 710061, Shaanxi, Peoples R China
[2] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Geratol, Xian 710061, Shaanxi, Peoples R China
[3] Yanan Univ, Sch Med, Yanan 716000, Shaanxi, Peoples R China
[4] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Geratol, 277 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China
基金
中国国家自然科学基金;
关键词
Weighted risk model; Diabetic kidney disease; Progression; Random forest; Dialysis; GLOMERULAR-FILTRATION-RATE; SERUM URIC-ACID; OUTCOMES; UPDATE; HYPERFILTRATION; ASSOCIATION; PREVALENCE; MANAGEMENT; HEALTH; IMPACT;
D O I
10.1186/s12967-023-04245-w
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BackgroundDiabetic kidney disease (DKD) is a severe complication of diabetes. Currently, no effective measures are available to reduce the risk of DKD progression. This study aimed to establish a weighted risk model to determine DKD progression and provide effective treatment strategies.MethodsThis was a hospital-based, cross-sectional study. A total of 1104 patients with DKD were included in this study. The random forest method was used to develop weighted risk models to assess DKD progression. Receiver operating characteristic curves were used to validate the models and calculate the optimal cutoff values for important risk factors.ResultsWe developed potent weighted risk models to evaluate DKD progression. The top six risk factors for DKD progression to chronic kidney disease were hemoglobin, hemoglobin A1c (HbA1c), serum uric acid (SUA), plasma fibrinogen, serum albumin, and neutrophil percentage. The top six risk factors for determining DKD progression to dialysis were hemoglobin, HbA1c, neutrophil percentage, serum albumin, duration of diabetes, and plasma fibrinogen level. Furthermore, the optimal cutoff values of hemoglobin and HbA1c for determining DKD progression were 112 g/L and 7.2%, respectively.ConclusionWe developed potent weighted risk models for DKD progression that can be employed to formulate precise therapeutic strategies. Monitoring and controlling combined risk factors and prioritizing interventions for key risk factors may help reduce the risk of DKD progression.
引用
收藏
页数:11
相关论文
共 40 条
  • [1] Kidney Disease and Increased Mortality Risk in Type 2 Diabetes
    Afkarian, Maryam
    Sachs, Michael C.
    Kestenbaum, Bryan
    Hirsch, Irl B.
    Tuttle, Katherine R.
    Hinnmelfarb, Jonathan
    de Boer, Ian H.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 24 (02): : 302 - 308
  • [2] Inflammatory Mechanisms as New Biomarkers and Therapeutic Targets for Diabetic Kidney Disease
    Alicic, Radica Z.
    Johnson, Emily J.
    Tuttle, Katherine R.
    [J]. ADVANCES IN CHRONIC KIDNEY DISEASE, 2018, 25 (02) : 181 - 191
  • [3] 6. Glycemic Targets: Standards of Medical Care in Diabetes-2022
    American Diabetes Association Professional Practice Committee
    [J]. DIABETES CARE, 2022, 45 : S83 - S96
  • [4] Amer Diabet Assoc Professional Pra, 2022, DIABETES CARE, V45, pS175, DOI [10.2337/dc22-ad08a, 10.2337/dc22-S011]
  • [5] Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical Diabetologists and the Renal Association UK guideline update 2021
    Banerjee, D.
    Winocour, P.
    Chowdhury, T. A.
    De, P.
    Wahba, M.
    Montero, R.
    Fogarty, D.
    Frankel, A. H.
    Karalliedde, J.
    Mark, P. B.
    Patel, D. C.
    Pokrajac, A.
    Sharif, A.
    Zac-Varghese, S.
    Bain, S.
    Dasgupta, I
    [J]. BMC NEPHROLOGY, 2022, 23 (01)
  • [6] Fructose and uric acid in diabetic nephropathy
    Bjornstad, Petter
    Lanaspa, Miguel A.
    Ishimoto, Takuji
    Kosugi, Tomoki
    Kume, Shinji
    Jalal, Diana
    Maahs, David M.
    Snell-Bergeon, Janet K.
    Johnson, Richard J.
    Nakagawa, Takahiko
    [J]. DIABETOLOGIA, 2015, 58 (09) : 1993 - 2002
  • [7] Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum
    Cefalu, William T.
    Buse, John B.
    Tuomilehto, Jaakko
    Fleming, G. Alexander
    Ferrannini, Ele
    Gerstein, Hertzel C.
    Bennett, Peter H.
    Ramachandran, Ambady
    Raz, Itamar
    Rosenstock, Julio
    Kahn, Steven E.
    [J]. DIABETES CARE, 2016, 39 (07) : 1186 - 1201
  • [8] Home Blood Pressure Monitoring in CKD
    Cohen, Debbie L.
    Huan, Yonghong
    Townsend, Raymond R.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2014, 63 (05) : 835 - 842
  • [9] Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)
    de Boer, Ian H.
    Khunti, Kamlesh
    Sadusky, Tami
    Tuttle, Katherine R.
    Neumiller, Joshua J.
    Rhee, Connie M.
    Rosas, Sylvia E.
    Rossing, Peter
    Bakris, George
    [J]. DIABETES CARE, 2022, 45 (12) : 3075 - 3090
  • [10] Intensive Diabetes Therapy and Glomerular Filtration Rate in Type 1 Diabetes
    de Boer, Ian H.
    Sun, Wanjie
    Cleary, Patricia A.
    Lachin, John M.
    Molitch, Mark E.
    Steffes, Michael W.
    Zinman, Bernard
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (25) : 2366 - 2376